Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin

European Journal of Pharmacology

Volumn 297, Issue 3, 1996, Pages 257-263

  Fujii, Emiko ^a   Irie, Kaoru ^a   Ogawa, Akira ^a   Ohba, Ken Ichi ^a   Muraki, Takamura ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Lipopolysaccharide; Mouse; Nitric oxide (NO); Prostaglandin; Skin; Vascular permeability

Indexed keywords

AMINOGUANIDINE; ANTIINFLAMMATORY AGENT; CYCLOHEXIMIDE; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DYE; INDOMETACIN; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PONTAMINE SKY BLUE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENANTIOMER; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SKIN;

EID: 0030066888     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00758-X     Document Type: Article

References (36)

1. Akarasereenont, P., J.A. Mitchell, Y.S. Bakhle, C. Thiemermann and J.R. Vane, 1995, Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages, Eur. J. Pharmacol. 273, 121.
2. Buchanan, J.E. and J.W. Phillis, 1993, The role of nitric oxide in the regulation of cerebral blood flow, Brain Res. 610, 248.
3. Casals-Stenzel, J., 1987, Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock, Eur. J. Pharmacol. 135, 117.
4. Corbett, J.A., R.G. Tilton, K. Chang, K.S. Hasan, Y. Ido, J.L. Wang, M.A. Sweetland, J.R. Lancaster, Jr., J.R. Williamson and M.L. McDaniel, 1992, Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction, Diabetes 41, 552.
5. Curran, R.D., T.R. Billiar, D.J. Stuehr, K. Hofmann and R.L. Simmons, 1989, Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells, J. Exp. Med. 170, 1769.
6. Cybulsky, M.I., M.K. Chan and H.Z. Movat, 1988, Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab. Invest. 58, 365.
7. Frasier-Scott, K., H. Hatzakis, D. Seong, C.M. Jones and K.K. Wu, 1988, Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism: induction of de novo synthesis of prostaglandin H synthase, J. Clin. Invest. 82, 1877.
8. Fujii, E., K. Irie, Y. Uchida, F. Tsukahara and T. Muraki, 1994, Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin, Naunyn-Schmied. Arch. Pharmacol. 350, 361.
9. Fujii, E., K. Irie, Y. Uchida, K. Ohba and T. Muraki, 1995, Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin, Eur. J. Pharmacol. 273, 267.
10. Geller, D.A., A.K. Nussler, M. Di Silvio, C.J. Lowenstein, R.A. Shapiro, S.C. Wang, R.L. Simmons and T.R. Billiar, 1993, Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes, Proc. Natl. Acad. Sci. USA 90, 522.
11. Gierse, J.K., S.D. Hauser, D.P. Creely, C. Koboldt, S.H. Rangwala, P.C. Isakson and K. Seibert, 1995, Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase, Biochem. J. 305, 479.
12. Hewett, J.A. and R.A. Roth, 1993, Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides, Pharmacol. Rev. 45, 381.
13. Ialenti, A., A. Ianaro, S. Moncada and M.D. Rosa, 1992, Modulation of acute inflammation by endogenous nitric oxide, Eur. J. Pharmacol. 211, 177.
14. Issekutz, A.C. and S. Bhimji, 1982, Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation, Infect. Immun. 36, 558.
15. Kilboum, R.G. and P. Belloni, 1990, Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1, or endotoxin, J. Natl. Cancer Inst. 82, 772.
16. Kopaniak, M.M., A.C. Issekutz and H.Z. Movat, 1980, Kinetics of acute inflammation induced by E. coli in rabbits: quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation, Am. J. Pathol. 98, 485.
17. Koide, M., Y. Kawahara, T. Tsuda and M. Yokoyama, 1993, Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells, FEBS Lett. 318, 213.
18. Liu, S., I.M. Adcock, R.W. Old, P.J. Bames and T.W. Evans, 1993, Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA, Biochem. Biophys. Res. Commun. 196, 1208.
19. Marietta, M.A., P.S. Yoon, R. Iyengar, C.D. Leaf and J.S. Wishnok, 1988, Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate, Biochemistry 27, 8706.
20. Masferrer, J.L., K. Seibert, B.S. Zweifel and P. Needleman, 1992, Endogenous glucocorticoids regulate an inducible cycooxygenase enzyme, Proc. Natl. Acad. Sci. USA 89, 3917.
21. Masferrer, J.L., S.T. Reddy, B.S. Zweifel, K. Seibert, P. Needleman, R.S. Gilbert and H.R. Herschman, 1994, In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages, J. Pharmacol. Exp. Ther. 270, 1340.
22. Mitchell, J.A., T.A. Swierkosz, T.D. Warner, S.S. Gross, C. Thiemermann and J.R. Vane, 1993, Regulation of prostacyclin synthesis by endogenous nitric oxide in response to bacterial lipopolysaccharide, Br. J. Pharmacol. 109, 4P.
23. Moncada, S., R.M.J. Palmer and E.A. Higgs, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev. 43, 109.
24. Moreno, J.J., X. Ferrer, E. Ortega and G. Carganico, 1992, PLA2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action, Agents Actions 36, 259.
25. Palmer, R.M.J., D.S. Ashton and S. Moncada, 1988, Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature 333, 664.
26. Radomski, M.W., R.M. Palmer and S. Moncada, 1990, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells, Proc. Natl. Acad. Sci. USA 87, 10043.
27. Rees, D.D., S. Cellek, R.M.J. Palmer and S. Moncada, 1990a, Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock, Biochem. Biophys. Res. Commun. 173, 541.
28. Rees, D.D., R.M.J. Palmer, R. Schulz, H.F. Hodson and S. Moncada, 1990b, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol. 101, 746.
29. Salvemini, D., R. Korbut, E. Anggard and J. Vane, 1990, Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide, Proc. Natl. Acad. Sci. USA 87, 2593.
30. Shukovski, L. and A. Tsafriri, 1994, The involvement of nitric oxide in the ovulatory process in the rat, Endocrinology 135, 2287.
31. Tilton, R.G., K. Chang, K.S. Hasan, S.R. Smith, J.M. Petrash, T.P. Misko, W.M. Moore, M.G. Currie, J.A. Corbett, M.L. McDaniel and J.R. Williamson, 1993, Prevention of diabetic vascular function by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes, 42, 221.
32. Udaka, K., Y. Takeuchi and H.Z. Movat, 1970, Simple method for quantitation of enhanced vascular permeability, Proc. Soc. Exp. Biol. Med. 133, 1384.
33. Utsunomiya, I., S. Nagai and S. Oh-ishi, 1994, Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy, Eur. J. Pharmacol. 252, 213.
34. Vane, J.R. and R.M. Botting, 1990, Mediators from the endothelial cell, Adv. Pros. Thromb. Leuk. Res. 21, 627.
35. Warren, J.B., M.L. Coughlan and T.J. Williams, 1992, Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis, Br. J. Pharmacol. 106, 953.
36. Williams, T.J. and M.J. Peck, 1977, Role of prostaglandin-mediated vasodilatation in inflammation, Nature 270, 530.